VACCIN CONTRE LE VIRUS RESPIRATOIRE SYNCYTIAL

The disclosure relates to respiratory syncytial vims (RSV) ribonucleic acid (RNA) vaccines, as well as methods of using the vaccines and compositions comprising the vaccines.

Saved in:
Bibliographic Details
Main Authors WANG, Dai, BETT, Andrew J, BAHL, Kapil, CIARAMELLA, Giuseppe, ESPESETH, Amy
Format Patent
LanguageFrench
Published 22.01.2020
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The disclosure relates to respiratory syncytial vims (RSV) ribonucleic acid (RNA) vaccines, as well as methods of using the vaccines and compositions comprising the vaccines.
Bibliography:Application Number: MA20180047787